Midodrine improves chronic hypotension in hemodialysis patients

American Journal of the Medical Sciences

Volumn 325, Issue 5, 2003, Pages 256-261

  Lin, Yuh Feng ^a   Wang, Jia Yi ^b   Denq, Jong Chyou ^a   Lin, Shih Hua ^a  

^a TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Dialysis; Hypotension; Midodrine; Uremia

Indexed keywords

MIDODRINE;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; AUTONOMIC DYSFUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HAND GRIP; HEART OUTPUT; HEART RATE; HEMODIALYSIS PATIENT; HEMODYNAMICS; HUMAN; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; PLASMA RENIN ACTIVITY; SYMPATHETIC FUNCTION; SYSTOLIC BLOOD PRESSURE; VALSALVA MANEUVER; VASCULAR RESISTANCE;

EID: 0038630803     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200305000-00002     Document Type: Article

References (30)

1. Daul AE, Wang XL, Michel MC, et al. Arterial hypotension in chronic hemodialyzed patients. Kidney Int 1987;32:728-35.
2. Tsai YT, Lin SH, Lee GC, et al. Arteriovenous fistula using transposed basilic vein in chronic hypotensive hemodialysis patients. Clin Nephrol 2002;57:376-80.
3. Victor RG, Henrich WL. Autonomic neuropathy and hemodynamic stability in end-stage renal disease patients. In: Henrich WL, editor. Principles and practice of dialysis. Baltimore: Williams & Wilkins; 1994. p. 196-208.
4. Kersh ES, Kronfiell SJ, Unger A, et al. Autonomic insufficiency in uremia as a cause of hemodialysis-induced hypotension. N Engl J Med 1974;290:650-3.
5. Moore TJ, Lazarus JM, Hakim RM, et al. Reduced angiotensin receptors and pressor responses in hypotensive hemodialysis patients. Kidney Int 1989;36:696-701.
6. Carretta R, Fabris B, Fischetti F, et al. Peripheral adrenoceptors in hypotension of hemodialyzed uremic patients. Nephron 1992;62:429-33.
7. Davies B, Bannester R, Sever P, et al. The pressor actions of noradrenaline, angiotensin II and saralasin in chronic autonomic failure treated with fludrocortisone. Br J Clin Pharmacol 1979;8:253-60.
8. Schirger A, Sheps SG, Thomas JE, et al. Midodrine. a new agent in the management of idiopathic orthostatic hypotension and Shy-Drager syndrome. Mayo Clin Proc 1981;56:429-33.
9. Kaufmann H, Brannan T, Krakoff L, et al. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology 1988;38:951-6.
10. Jankovic J, Gilden JL, Hiner BC, et al. Neurologic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med 1993;95:38-48.
11. Alappan R, Cruz D, Abu-alfa AK, et al. Treatment of severe intradialytic hypotension with the addition of high dialysate calcium concentration to midodrine and/or cool dialysate. Am J Kidney Dis 2001;37:294-9.
12. Hoeben H, Abu-alfa AK, Mahnensmith R et al. Hemodynamics in patients with intradialytic hypotension treated with cool dialysate or midodrine. Am J Kidney Dis 2002;39:102-7.
13. Cruz DN, Mahnensmith RL, Brickel HM, et al. Midodrine is effective and safe therapy for intradialytic hypotension over 8 months of follow-up. Clin Nephrol 1998;50:101-7.
14. Lin YF, Wang JY, Shum AYC, et al. Role of plasma catecholamines, autonomic, and left ventricular function in normotensive and hypotension prone dialysis patients. ASAIO J 1993;39:946-53.
15. Malik S, Winney RJ, Ewing DJ. Chronic renal failure and cardiovascular autonomic function. Nephron 1986;43:191-5.
16. McLeod JG, Tuck RR. Disorders of the autonomic nervous system (part 2): investigation and treatment. Ann Neurol 1987;21:519-29.
17. Miach PJ, Dawborn JK, Louis WJ, et al. Left ventricular function in uremia: echocardiographic assessment in patients on maintenance dialysis. Clin Nephrol 1981;15:259-63.
18. Lin SH, Chu P, Yu FC, et al. Increased nitric oxide production in hypotensive haemodialysis patients. ASAIO J 1996;42:M895-9.
19. Sorensen SS, Danielsen H, Jespersen B, et al. Hypotension in end-stage renal disease: effect of postural change, exercise and angiotensin II infusion on blood pressure and plasma concentrations of angiotensin II, aldosterone, and arginine vasopressin in hypotensive patients with chronic renal failure treated by dialysis. Clin Nephrol 1986;26:288-96.
20. Rascher W, Schomig A, Kreye VA, et al. Diminished vascular response to noradrenaline in experimental chronic uremia. Kidney Int 1982;21:20-7.
21. Hui KK, Conolly ME. Increased numbers of beta-receptors in orthostatic hypotension due to autonomic dysfunction. N Engl J Med 1981;304:1473-6.
22. Imai Y, Abe K, Otsuka Y, et al. Blood pressure regulation in chronic hypotensive and hypertensive patients with chronic failure. Jpn Circ J 1981;45:303-14.
23. Tajiri M. A clinical study of persistent hypotension in patients on chronic hemodialysis. Jpn J Nephrol 1993;35:223-31.
24. Fang JT, Huang CC. Midodrine hydrochloride in patients on hemodialysis with chronic hypotension. Ren Fail 1996;18:253-60.
25. Blowey DL, Balfe JW, Gupta I, et al. Midodrine efficiacy and pharmacokinetics in a patient with recurrent intradialytic hypotension. Am J Kidney Dis 1996;28:132-6.
26. Montagnac R, Clavel P, Delhotal-Landes B, et al. Use of midodrine (Gutron) to treat permanent hypotension in a chronic hemodialysis patient. Clin Nephrol 2001;56:162-8.
27. Taylor AA. Autonomic control of cardiovascular function: clinical evaluation in health and disease. J Clin Pharmacol 1994;34:363-74.
28. Zoccali C, Ciccarelli M, Mallamaci F, et al. The role of endogenous opioids in the baroreflex dysfunction of dialysis patients. Nephrol Dial Transplant 1985;21:190-4.
29. Jimbo M, Suzuki H, Ichikawa M, et al. Role of nitric oxide in regulation of baroreceptor reflex. J Auton Nerv Syst 1994;50:209-19.
30. Zanzinger J, Czachurski J, Seller H. Inhibition of basal and reflex-mediated sympathetic activity in the RVLM by nitric oxide. Am J Physiol 1995;268:R958-62.